Expansion of human cord blood CD34+CD38- cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function

Blood

Volumn 95, Issue 1, 2000, Pages 102-110

  Dorrell, Craig ^b   Gan, Olga I ^b   Pereira, Daniel S ^b   Hawley, Robert G ^b   Dick, John E ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL CULTURE; CELL FUNCTION; CELL POPULATION; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; STEM CELL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0033964863     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.1.102     Document Type: Article

References (47)

1. Verma I, Somia N. Gene therapy - promises, problems, and prospects. Nature. 1996;389:239-242.
2. Koller MR, Emerson SG, Palsson BO. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood. 1993;82:378-384.
3. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ. Self-renewal of primitive human cells (long term culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci U S A. 1996;93:1470-1474.
4. Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89:2644-2653.
5. + cells. Blood. 1997;90:3903-3913.
6. Dick JE. Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol. 1996;4: 197-206.
7. Dick JE, Bhatia M, Gan O, Kapp U, Wang JCY. Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells. 1997;15(suppl 1): 199-203.
8. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2:1329-1337.
9. Bhatia M, Wang XY, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997;94:5320-5325.
10. Gan OI, Murdoch B, Larochelle A, Dick JE. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells. Blood. 1997;90:641-650.
11. Bhatia M, Bonnet D, Kapp U, Wang JCY, Murdoch B, Dick JE. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 1997;186:619-624.
12. Conneally E, Cashman J, Petzer A, Eaves CJ. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A. 1997;94:9836-9841.
13. Mulligan R. The basic science of gene therapy. Science. 1993;260:926-932.
14. Brenner MK, Rill DR, Holladay MS, et al. Gene marking to determine whether autologous marrow infusion restores long-term hematopoiesis in cancer patients. Lancet. 1993;342:1134-1137.
15. Deisseroth AB, Zu Z, Claxton D, et al Genetic marking shows that ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse. Blood. 1994;83: 3068-3076.
16. Kohn DB, Weinberg KI, Nolta JA, et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med. 1995;1:1017-1023.
17. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood. 1995;85:3048-3057.
18. + cells in ADA-deficient SCID neonates. Nat Med. 1998;4:775-780.
19. Conneally E, Eaves CJ, Humphries RK. Efficient retroviral-mediated gene transter to human cord blood stem cells with in vivo repopulating potential. Blood. 1998;91:3487-3493.
20. low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. Hum Gene Ther. 1998;9:1497-1511.
21. Schilz AJ, Brauns G, Knöß H, et al. High efficiency gene transfer to human hematopoietic SCID-repopulating cells under serum-free conditions. Blood. 1998;92:3163-3171.
22. van Hennik PB, Verstagen MM, Bierhuizen MF, et al. Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. Blood. 1998; 92:4013-4022.
23. Rebel VI, Tanaka M, Lee JS, et al. One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus. Blood. 1999;93:2217-2224.
24. Civin CI, Gore SD. Antigenic analysis of hematopoiesis: a review. J Hematother. 1993;2:137-144.
25. +CD38 progenitor cells. Blood. 1991;77:1218-1227.
26. +CD38 cells in cord blood and bone marrow. Blood. 1995;86:3745-3753.
27. Hao QL, Thiemann FT, Petersen D, Smogorzewska EM, Crooks GM. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood. 1996;88:3306-3313.
28. Muench MO, Cupp J, Polakoff J, Roncarolo MG. Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferate potential. Blood. 1994;83:3170-3181.
29. Cheng L, Du C, Murray D, et al. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther. 1997;4:1013-1022.
30. Wang Y, Kuropatwinski KK, White DW, et al. Leptin receptor action in hepatic cells. J Biol Chem. 1997;272:16,216-16,223.
31. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multi-lineage hematopoiesis from immature human cells engrafted in SCID mice. Science. 1992;255: 1137-1141.
32. Croisille L, Auffray I, Katz A, Izac B, Vainchenker W, Coulombel L. Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34+ +/CD38- long-term culture-initiating cells. Blood. 1994;84:4116-4124.
33. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human repopulating cells with SCID-repopulating activity. Nat Med. 1998;4:1038-1045.
34. Bonnet D, Bhatia M, Wang JCY, Kapp U, Dick JE. Cytokine treatment or accessory cells to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant. 1999; 3:203-209.
35. Kamel-Reid S, Dick JE. Engraftment of immunedeficient mice with human hematopoietic stem cells. Science. 1988;242:1706-1709.
36. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies: I. Data analysis. J Immunol. 1981;126:1614-1619.
37. Yonemura Y, Ku H, Hirayama F, Souza LM, Ogawa M. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci U S A. 1996;93:4040-4044.
38. Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci U S A. 1997;94:4698-4703.
39. Gan OI, Dorrell C, Pereira D, Ito C, Wang JCY, Dick JE. Characterization and retroviral transduction of an early human lymphomyeloid precursor assayed in non-switched long-term culture on murine stroma. Exp Hematol. 1999;27:1097-1106.
40. Sekhar M, Kotani H, Doren S, Agarwal R, McGarrity G, Dunbar CE. Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions. Hum Gene Ther. 1996;7:33-38.
41. Glimm H, Flugge K, Mobest D, et al. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium. Hum Gene Ther. 1998;9:771-778.
42. lo human marrow cells after in vitro cytokine exposure. Blood. 1995;85:1480-1487.
43. McCowage GB, Phillips KL, Gentry TL, et al. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells. Exp Hematol. 1998;26:288-298.
44. + cells in serum-free cultures containing steel factor, interleukin-6, and erythropoietin with maintenance of cell with long-term reconstituting potential. Blood. 1994;83:128-136.
45. Shubinsky G, Schlesinger M. The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity. 1997;7:315-324.
46. Shubinsky G, Schlesinger M. The mechanism of interleukin-4-induced downregulation of CD38 on human B cells. Cell Immunol. 1997;173:87-95.
47. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283: 845-848.